CLINICAL_TRIALS
ClinicalTrials.gov record update
A Prospective, Multi-center, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the OR3O™ Dual Mobility System Versus Conventional Single Bearing Design Total Hip System in Primary Total Hip Arthroplasty (THA) Procedures.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04941729
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:46.419274+00:00
- Published At
- 2025-05-21T00:00:00+00:00
- Record Updated At
- 2025-05-21
- Results Posted At
- 2025-05-21
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Degenerative Hip Joint Disease", "Rheumatoid Arthritis (RA)", "Femoral Neck Fractures", "Avascular Necrosis of Femoral Head", "Osteoarthritis (OA)", "Hip Dislocation", "Hip Fractures"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-21"- protocolSection.identificationModule.nctId
"NCT04941729"- protocolSection.identificationModule.officialTitle
"A Prospective, Multi-center, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the OR3O\u2122 Dual Mobility System Versus Conventional Single Bearing Design Total Hip System in Primary Total Hip Arthroplasty (THA) Procedures."- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-05-21"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.